Integra Lifesciences Holdings Corp (IART) 47.24 $IART
Integra LifeSciences to Host Its Second Quarter 2014 Earnings Results Conference Call on August 5, 2014
GlobeNewswire - Thu Jul 10, 3:00PM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2014 financial results on Tuesday, August 5, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
IART Crosses Below Key Moving Average Level
MarketNewsVideo.com - Thu Jul 10, 12:08PM CDT
In trading on Thursday, shares of Integra LifeSciences Holdings Corp crossed below their 200 day moving average of $45.72, changing hands as low as $45.07 per share. Integra LifeSciences Holdings Corp shares are currently trading up about 0.1% on...
Integra LifeSciences renews & extends credit facility
M2 - Thu Jul 10, 7:40AM CDT
Medical technology company Integra LifeSciences Holdings (NasdaqGS:IART) disclosed on Wednesday a rise in the size of the credit facility plus an extended maturity date under the new terms
Integra LifeSciences Announces Renewal and Extension of Credit Facility
GlobeNewswire - Wed Jul 09, 3:15PM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including an increase in the size of the facility and an extended maturity date, with its bank group led by Bank of America, N.A. and Wells Fargo Bank.
Integra Upbeat on DuraSeal Acquisition despite Tepid Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 2:10PM CDT
On Jul 3, 2014, we initiated coverage on Integra LifeSciences Holdings Corpopration (IART).
MediPoint: Spinal Fusion - EU Analysis and Market Forecasts to 2020
M2 - Wed Jul 02, 3:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6tv7pb/medipoint_spinal) has announced the addition of the "MediPoint: Spinal Fusion - EU Analysis and Market Forecasts" report to their offering. The specific anatomical regions being operated on are covered, including cervical and thoracolumbar. Furthermore, this report analyzes the adoption of these implantables in single-, double-, and triple-level surgeries, creating the most comprehensive and accurate market valuations and coverage. The report analyzes how these surgical trends vary in the major markets in European Union including France, Germany, Italy, Spain, and the United Kingdom (UK). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview - Spinal Plating Systems - Interbody Cages - Pedicle Screw Systems 4 Market Dynamics: Mergers, Acquisitions and Key Partnerships - Amedica Corporation Acquires US Spine - Alphatec Spine Acquires Scient'x Group - Biomet Acquires Lanx, Inc. - Globus Medical Acquires Facet Solutions - Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc. - Medtronic Acquires Advanced Medical Technologies and China's Kanghui - Nuvasive Acquires ANC - TranS1 Inc. Acquires Baxano Inc. 5 Unmet Needs - Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures - Lack of Definitive Methods to Determine Fusion Performance - Technological Developments in the Use of Long Fusions - Research and Development into Fusion Enhancers - Improve Osseointegration of Bone and Screw Interface 6 Market Opportunity Analysis - Develop Signature Minimally Invasive Technique - Market Minimally Invasive Training Opportunities to Fellowship Programs - Increased Collaboration of Medical Device Implants and Biologics - Develop a Device that Provides Real-Time Fusion Updates - Increased Customization of Spinal Implants to Patient Anatomy 7 Market Drivers - Aging Patient Populations - Growth in the Spinal Stenosis Indication - Gold Standard for Treating Spinal Instability and Degenerative Conditions - Treatment for a Variety of Indications - Preference for Minimally Invasive Techniques - Advances in Navigation Technology 8 Market Barriers - Incidence of Adjacent Segment Disease - Performance of Non-Fusion Technologies - Increased Scrutiny over Spinal Fusion's Necessity in the US - Restricted Reimbursement from Private Payers - Performance in Treating Axial Back Pain 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players - Aesculap - Alphatec Spine - Amedica Corporation - Medtronic Spinal and Biologics - DePuy Spine - Globus Medical - K2M - Biomet - Stryker - Zimmer - Nuvasive - Orthofix - Integra LifeSciences 12 Market Outlook 13 Appendix For more information visit http://www.researchandmarkets.com/research/6t...int_spinal
Integra Lifesciences Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 4:30PM CDT
On Jun 26, 2014, Zacks Investment Research downgraded Integra Lifesciences Holdings Corporation (IART) to a Zacks Rank #4 (Sell).
World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) 2013-2017
M2 - Mon Jun 30, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4h95wb/the_world_market) has announced the addition of the "The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)" report to their offering. The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body by surgical instruments. In most instances, a catheter is a thin, flexible tube, though there is great diversity in catheter types and applications. This report provides descriptions of the types of catheters and estimates their market size and discusses the competitive activity in each category. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. This is a minimally invasive procedure in which a catheter is guided into the heart, usually through a blood vessel in the leg or arm. Once inside the heart, it can be used for diagnosing or treating a condition. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia. The purpose of the drain is to remove fluid or blood from the surgical site. This helps the healing process. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize on the World Market for Catheters. This report is a comprehensive look at the market of these critical medical devices. Which segments of catheters provide the most opportunity? Which are growing the fastest? Who are the key players and what share do they have of the market? What are the critical issues and trends that will drive catheter sales in the future. What pitfalls do manufacturers need to be aware of? These questions and more are answered in this report. This report contains global market size and forecast to 2017 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters Suction Catheters Wound Drainage Catheters Company profiles are included, with profiles of the following companies: - Abbott - Angio Dynamics - Atrium Medical - Bactiguard AB - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Edwards Lifesciences - Greatbatch Medical - Johnson & Johnson - Hansen Medical - Iapyx Medical - Integra LifeSciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St. Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/4h...rld_market
Integra LifeSciences Celebrates 25th Anniversary
GlobeNewswire - Thu Jun 19, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in medical technology, today announced that June 2014 marks the 25 anniversary of its founding.
MediPoint: Spinal Fusion - Global Analysis and Market Forecasts 2014-2020
M2 - Wed Jun 18, 5:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f4hrzb/medipoint_spinal) has announced the addition of the "MediPoint: Spinal Fusion - Global Analysis and Market Forecasts" report to their offering. The authors estimates that the spinal fusion market in 2013 was valued at $4,775m across the 10 regions covered in this report, which include the United States (US), France, Germany, Italy, Spain, the United Kingdom (UK), Japan, Brazil, India and China. By the end of the forecast period in 2020, sales will have grown to $6,982m, with a Compound Annual Growth Rate (CAGR) of 5.58%. Global Outlook United States will continue to occupy the majority of the global spinal fusion market through 2020. The country's global market share will decline over the forecast from 71% in 2013 to 63% in 2020. It will also experience one of the lowest CAGRs over the forecast given how mature the market is in the country and newly enacted reimbursement hurdles from public health payers. Like other medical device markets, emerging economies will be a source of large growth rates over the forecast period. For example, China will experience double digit growth rates through 2020 and this will increase its global market share from 5% in 2013 to 10% in 2020. Additionally, select established economies in the European Union will experience large growth rates over the forecast period including the United Kingdom and Italy. The primary reason for their growth is the increasing procedure volumes for spinal fusion surgeries owing to favorable reimbursement levels and patient's willingness to undergo surgery with minimally invasive techniques. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview - Spinal Plating Systems - Interbody Cages - Pedicle Screw Systems 4 Market Dynamics: Mergers, Acquisitions and Key Partnerships - Amedica Corporation Acquires US Spine - Biomet Acquires Lanx, Inc. - Globus Medical Acquires Facet Solutions - Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc. - Medtronic Acquires Advanced Medical Technologies and China's Kanghui - Nuvasive Acquires ANC - TranS1 Inc. Acquires Baxano Inc. 5 Unmet Needs - Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures - Lack of Definitive Methods to Determine Fusion Performance - Technological Developments in the Use of Long Fusions - Research and Development into Fusion Enhancers - Improve Osseointegration of Bone and Screw Interface 6 Market Opportunity Analysis - Develop Signature Minimally Invasive Technique - Market Minimally Invasive Training Opportunities to Fellowship Programs - Increased Collaboration of Medical Device Implants and Biologics - Develop a Device that Provides Real-Time Fusion Updates - Increased Customization of Spinal Implants to Patient Anatomy 7 Market Drivers - Aging Patient Populations - Growth in the Spinal Stenosis Indication - Gold Standard for Treating Spinal Instability and Degenerative Conditions - Treatment for a Variety of Indications - Preference for Minimally Invasive Techniques - Advances in Navigation Technology 8 Market Barriers - Incidence of Adjacent Segment Disease - Performance of Non-Fusion Technologies - Increased Scrutiny over Spinal Fusion's Necessity in the US - Restricted Reimbursement from Private Payers - Performance in Treating Axial Back Pain 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players - Aesculap - Alphatec Spine - Amedica Corporation - Medtronic Spinal and Biologics - DePuy Spine - Globus Medical - K2M - Biomet - Stryker - Zimmer - Nuvasive - Orthofix - Integra LifeSciences 12 Market Outlook - Spinal Plating Systems - Interbody Cages - Pedicle Screw Systems 13 Appendix For more information visit http://www.researchandmarkets.com/research/f4...int_spinal
Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 1:50PM CDT
The new agreement will allow Integra LifeSciences (IART) to meet Premier's needs for orthopedic devices.
Integra LifeSciences Announces Contract with Premier, Inc.
GlobeNewswire - Thu Jun 12, 7:47AM CDT
Integra LifeSciences Holding Corporation (Nasdaq:IART) today announced that its Orthopedics and Tissue Technologies group signed a three-year group purchasing contract with Premier, Inc., a leading healthcare improvement company. The agreement will offer small bone orthopedic implants to Premier alliance members.
Integra Lifesciences Down to Sell on Poor Q1 Segment Show - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 10, 2:40PM CDT
Integra Lifesciences' (IART) management has lowered its adjusted earnings guidance, primarily reflecting the negative impact of the change in accounting policy for the medical device excise tax.
Global Surgical Equipment Market Research Report 2014-2019
M2 - Tue May 27, 2:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/p5q3ld/surgical) has announced the addition of the "Surgical Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The market for surgical equipment has been broadly segmented into surgical sutures and staples, surgical handheld instruments and electrosurgical devices. In 2012, this segment accounted for 55.6% of the total surgical equipment market. Of these, surgical sutures held the larger share than staples in 2012. The two major types of sutures are absorbable and non-absorbable sutures depending on the body's ability to degrade and absorb the suture materials over time. Absorbable sutures are in greater demand over non-absorbable sutures owing to their increasing adoption across most surgical procedures except those which require permanent sutures or long-term care. The surgical handheld instruments market includes scalpels, forceps, retractors and scissors. Electrosurgical devices include radiofrequency generators, instruments and other accessories, which are used during various surgical procedures to cut, cauterize, coagulate and ligate tissues and luminal structures by utilizing high frequency electric current. This segment has been anticipated as the fastest growing segment during the forecast period 2013 to 2019. Each segment of the surgical equipment market is dominated by a select number of players. For instance the market for surgical sutures and staples market is dominated by mainly Ethicon, Inc., B. Braun Melsungen AG and Covidien plc. These players have stronghold on group purchasing organizations (GPOs) in the U.S. market where healthcare providers collectively purchase surgical instruments at low prices. The market for surgical handheld instruments is largely fragmented and is distributed between multinationals and local manufacturers. Globally, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Covidien plc and Aspen Surgical Products, Inc. are the major players operating in the surgical handheld instruments market. Surgical Equipment Market, by Product Type - Surgical Sutures and Staples - - Surgical Sutures - - Surgical Staples - Surgical Handheld Instruments - - Scalpels - - Forceps - - Retractors - - Scissors - Electrosurgical Devices Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Surgical Equipment Market Revenue, by Product Type, 2010 - 2019 (USD Million) Chapter 5 Global Surgical Equipment Market Revenue, by Geography, 2011 - 2019 (USD Million) Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Aspen Surgical Products, Inc. - B. Braun MelsungenAG - CONMED Corporation - CareFusion Corporation - Covidien plc - ERBE Elektromedizin GmbH - Ethicon, Inc. - Integra LifeSciences Holdings Corporation - KLS Martin LP - Medicon eG - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/p5q3ld/surgical
Integra LifeSciences to Participate in the Jefferies 2014 Global Healthcare Conference in June
GlobeNewswire - Fri May 23, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences next month:
Integra LifeSciences Introduces Wound Matrix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:34PM CDT
New Jersey-based Integra LifeSciences Holding Corporation (IART) has expanded its skin and wound product line with the launch of Integra Wound Matrix (Thin).
Integra LifeSciences Launches Integra(R) Wound Matrix (Thin)
GlobeNewswire - Tue Mar 25, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of Integra Wound Matrix (Thin). Integra Wound Matrix (Thin) has received 510(k) clearance from the United States Food and Drug Administration (FDA) and expects to begin a full market release in the United States in April 2014. Integra's newest skin product will be featured at the American Burn Association Annual Meeting, March 25 - 28, 2014, in Boston, Massachusetts.
Use Options For A Chance To Buy IART At A 28% Discount
at The Street - Fri Mar 21, 10:57AM CDT
Looking back to 135 days ago, Integra LifeSciences Holdings Corp priced a 3,500,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go...
First Laminoplasty Implant at Integra - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 5:00PM CDT
Integra LifeSciences announced the first human implantation of its Laminoplasty System in the U.S.
Integra LifeSciences to Host Its Second Quarter 2014 Earnings Results Conference Call on August 5, 2014
GlobeNewswire - Thu Jul 10, 3:00PM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2014 financial results on Tuesday, August 5, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
IART Crosses Below Key Moving Average Level
MarketNewsVideo.com - Thu Jul 10, 12:08PM CDT
In trading on Thursday, shares of Integra LifeSciences Holdings Corp crossed below their 200 day moving average of $45.72, changing hands as low as $45.07 per share. Integra LifeSciences Holdings Corp shares are currently trading up about 0.1% on...
Integra LifeSciences renews & extends credit facility
M2 - Thu Jul 10, 7:40AM CDT
Medical technology company Integra LifeSciences Holdings (NasdaqGS:IART) disclosed on Wednesday a rise in the size of the credit facility plus an extended maturity date under the new terms
Integra LifeSciences Announces Renewal and Extension of Credit Facility
GlobeNewswire - Wed Jul 09, 3:15PM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including an increase in the size of the facility and an extended maturity date, with its bank group led by Bank of America, N.A. and Wells Fargo Bank.
Integra Upbeat on DuraSeal Acquisition despite Tepid Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 2:10PM CDT
On Jul 3, 2014, we initiated coverage on Integra LifeSciences Holdings Corpopration (IART).
MediPoint: Spinal Fusion - EU Analysis and Market Forecasts to 2020
M2 - Wed Jul 02, 3:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6tv7pb/medipoint_spinal) has announced the addition of the "MediPoint: Spinal Fusion - EU Analysis and Market Forecasts" report to their offering. The specific anatomical regions being operated on are covered, including cervical and thoracolumbar. Furthermore, this report analyzes the adoption of these implantables in single-, double-, and triple-level surgeries, creating the most comprehensive and accurate market valuations and coverage. The report analyzes how these surgical trends vary in the major markets in European Union including France, Germany, Italy, Spain, and the United Kingdom (UK). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview - Spinal Plating Systems - Interbody Cages - Pedicle Screw Systems 4 Market Dynamics: Mergers, Acquisitions and Key Partnerships - Amedica Corporation Acquires US Spine - Alphatec Spine Acquires Scient'x Group - Biomet Acquires Lanx, Inc. - Globus Medical Acquires Facet Solutions - Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc. - Medtronic Acquires Advanced Medical Technologies and China's Kanghui - Nuvasive Acquires ANC - TranS1 Inc. Acquires Baxano Inc. 5 Unmet Needs - Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures - Lack of Definitive Methods to Determine Fusion Performance - Technological Developments in the Use of Long Fusions - Research and Development into Fusion Enhancers - Improve Osseointegration of Bone and Screw Interface 6 Market Opportunity Analysis - Develop Signature Minimally Invasive Technique - Market Minimally Invasive Training Opportunities to Fellowship Programs - Increased Collaboration of Medical Device Implants and Biologics - Develop a Device that Provides Real-Time Fusion Updates - Increased Customization of Spinal Implants to Patient Anatomy 7 Market Drivers - Aging Patient Populations - Growth in the Spinal Stenosis Indication - Gold Standard for Treating Spinal Instability and Degenerative Conditions - Treatment for a Variety of Indications - Preference for Minimally Invasive Techniques - Advances in Navigation Technology 8 Market Barriers - Incidence of Adjacent Segment Disease - Performance of Non-Fusion Technologies - Increased Scrutiny over Spinal Fusion's Necessity in the US - Restricted Reimbursement from Private Payers - Performance in Treating Axial Back Pain 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players - Aesculap - Alphatec Spine - Amedica Corporation - Medtronic Spinal and Biologics - DePuy Spine - Globus Medical - K2M - Biomet - Stryker - Zimmer - Nuvasive - Orthofix - Integra LifeSciences 12 Market Outlook 13 Appendix For more information visit http://www.researchandmarkets.com/research/6t...int_spinal
Integra Lifesciences Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 4:30PM CDT
On Jun 26, 2014, Zacks Investment Research downgraded Integra Lifesciences Holdings Corporation (IART) to a Zacks Rank #4 (Sell).
World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) 2013-2017
M2 - Mon Jun 30, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4h95wb/the_world_market) has announced the addition of the "The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)" report to their offering. The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body by surgical instruments. In most instances, a catheter is a thin, flexible tube, though there is great diversity in catheter types and applications. This report provides descriptions of the types of catheters and estimates their market size and discusses the competitive activity in each category. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. This is a minimally invasive procedure in which a catheter is guided into the heart, usually through a blood vessel in the leg or arm. Once inside the heart, it can be used for diagnosing or treating a condition. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia. The purpose of the drain is to remove fluid or blood from the surgical site. This helps the healing process. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize on the World Market for Catheters. This report is a comprehensive look at the market of these critical medical devices. Which segments of catheters provide the most opportunity? Which are growing the fastest? Who are the key players and what share do they have of the market? What are the critical issues and trends that will drive catheter sales in the future. What pitfalls do manufacturers need to be aware of? These questions and more are answered in this report. This report contains global market size and forecast to 2017 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters Suction Catheters Wound Drainage Catheters Company profiles are included, with profiles of the following companies: - Abbott - Angio Dynamics - Atrium Medical - Bactiguard AB - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Edwards Lifesciences - Greatbatch Medical - Johnson & Johnson - Hansen Medical - Iapyx Medical - Integra LifeSciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St. Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/4h...rld_market
Integra LifeSciences Celebrates 25th Anniversary
GlobeNewswire - Thu Jun 19, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in medical technology, today announced that June 2014 marks the 25 anniversary of its founding.
MediPoint: Spinal Fusion - Global Analysis and Market Forecasts 2014-2020
M2 - Wed Jun 18, 5:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f4hrzb/medipoint_spinal) has announced the addition of the "MediPoint: Spinal Fusion - Global Analysis and Market Forecasts" report to their offering. The authors estimates that the spinal fusion market in 2013 was valued at $4,775m across the 10 regions covered in this report, which include the United States (US), France, Germany, Italy, Spain, the United Kingdom (UK), Japan, Brazil, India and China. By the end of the forecast period in 2020, sales will have grown to $6,982m, with a Compound Annual Growth Rate (CAGR) of 5.58%. Global Outlook United States will continue to occupy the majority of the global spinal fusion market through 2020. The country's global market share will decline over the forecast from 71% in 2013 to 63% in 2020. It will also experience one of the lowest CAGRs over the forecast given how mature the market is in the country and newly enacted reimbursement hurdles from public health payers. Like other medical device markets, emerging economies will be a source of large growth rates over the forecast period. For example, China will experience double digit growth rates through 2020 and this will increase its global market share from 5% in 2013 to 10% in 2020. Additionally, select established economies in the European Union will experience large growth rates over the forecast period including the United Kingdom and Italy. The primary reason for their growth is the increasing procedure volumes for spinal fusion surgeries owing to favorable reimbursement levels and patient's willingness to undergo surgery with minimally invasive techniques. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview - Spinal Plating Systems - Interbody Cages - Pedicle Screw Systems 4 Market Dynamics: Mergers, Acquisitions and Key Partnerships - Amedica Corporation Acquires US Spine - Biomet Acquires Lanx, Inc. - Globus Medical Acquires Facet Solutions - Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc. - Medtronic Acquires Advanced Medical Technologies and China's Kanghui - Nuvasive Acquires ANC - TranS1 Inc. Acquires Baxano Inc. 5 Unmet Needs - Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures - Lack of Definitive Methods to Determine Fusion Performance - Technological Developments in the Use of Long Fusions - Research and Development into Fusion Enhancers - Improve Osseointegration of Bone and Screw Interface 6 Market Opportunity Analysis - Develop Signature Minimally Invasive Technique - Market Minimally Invasive Training Opportunities to Fellowship Programs - Increased Collaboration of Medical Device Implants and Biologics - Develop a Device that Provides Real-Time Fusion Updates - Increased Customization of Spinal Implants to Patient Anatomy 7 Market Drivers - Aging Patient Populations - Growth in the Spinal Stenosis Indication - Gold Standard for Treating Spinal Instability and Degenerative Conditions - Treatment for a Variety of Indications - Preference for Minimally Invasive Techniques - Advances in Navigation Technology 8 Market Barriers - Incidence of Adjacent Segment Disease - Performance of Non-Fusion Technologies - Increased Scrutiny over Spinal Fusion's Necessity in the US - Restricted Reimbursement from Private Payers - Performance in Treating Axial Back Pain 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players - Aesculap - Alphatec Spine - Amedica Corporation - Medtronic Spinal and Biologics - DePuy Spine - Globus Medical - K2M - Biomet - Stryker - Zimmer - Nuvasive - Orthofix - Integra LifeSciences 12 Market Outlook - Spinal Plating Systems - Interbody Cages - Pedicle Screw Systems 13 Appendix For more information visit http://www.researchandmarkets.com/research/f4...int_spinal
Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 1:50PM CDT
The new agreement will allow Integra LifeSciences (IART) to meet Premier's needs for orthopedic devices.
Integra LifeSciences Announces Contract with Premier, Inc.
GlobeNewswire - Thu Jun 12, 7:47AM CDT
Integra LifeSciences Holding Corporation (Nasdaq:IART) today announced that its Orthopedics and Tissue Technologies group signed a three-year group purchasing contract with Premier, Inc., a leading healthcare improvement company. The agreement will offer small bone orthopedic implants to Premier alliance members.
Integra Lifesciences Down to Sell on Poor Q1 Segment Show - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 10, 2:40PM CDT
Integra Lifesciences' (IART) management has lowered its adjusted earnings guidance, primarily reflecting the negative impact of the change in accounting policy for the medical device excise tax.
Global Surgical Equipment Market Research Report 2014-2019
M2 - Tue May 27, 2:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/p5q3ld/surgical) has announced the addition of the "Surgical Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The market for surgical equipment has been broadly segmented into surgical sutures and staples, surgical handheld instruments and electrosurgical devices. In 2012, this segment accounted for 55.6% of the total surgical equipment market. Of these, surgical sutures held the larger share than staples in 2012. The two major types of sutures are absorbable and non-absorbable sutures depending on the body's ability to degrade and absorb the suture materials over time. Absorbable sutures are in greater demand over non-absorbable sutures owing to their increasing adoption across most surgical procedures except those which require permanent sutures or long-term care. The surgical handheld instruments market includes scalpels, forceps, retractors and scissors. Electrosurgical devices include radiofrequency generators, instruments and other accessories, which are used during various surgical procedures to cut, cauterize, coagulate and ligate tissues and luminal structures by utilizing high frequency electric current. This segment has been anticipated as the fastest growing segment during the forecast period 2013 to 2019. Each segment of the surgical equipment market is dominated by a select number of players. For instance the market for surgical sutures and staples market is dominated by mainly Ethicon, Inc., B. Braun Melsungen AG and Covidien plc. These players have stronghold on group purchasing organizations (GPOs) in the U.S. market where healthcare providers collectively purchase surgical instruments at low prices. The market for surgical handheld instruments is largely fragmented and is distributed between multinationals and local manufacturers. Globally, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Covidien plc and Aspen Surgical Products, Inc. are the major players operating in the surgical handheld instruments market. Surgical Equipment Market, by Product Type - Surgical Sutures and Staples - - Surgical Sutures - - Surgical Staples - Surgical Handheld Instruments - - Scalpels - - Forceps - - Retractors - - Scissors - Electrosurgical Devices Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Surgical Equipment Market Revenue, by Product Type, 2010 - 2019 (USD Million) Chapter 5 Global Surgical Equipment Market Revenue, by Geography, 2011 - 2019 (USD Million) Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Aspen Surgical Products, Inc. - B. Braun MelsungenAG - CONMED Corporation - CareFusion Corporation - Covidien plc - ERBE Elektromedizin GmbH - Ethicon, Inc. - Integra LifeSciences Holdings Corporation - KLS Martin LP - Medicon eG - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/p5q3ld/surgical
Integra LifeSciences to Participate in the Jefferies 2014 Global Healthcare Conference in June
GlobeNewswire - Fri May 23, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences next month:
Integra LifeSciences Introduces Wound Matrix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:34PM CDT
New Jersey-based Integra LifeSciences Holding Corporation (IART) has expanded its skin and wound product line with the launch of Integra Wound Matrix (Thin).
Integra LifeSciences Launches Integra(R) Wound Matrix (Thin)
GlobeNewswire - Tue Mar 25, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of Integra Wound Matrix (Thin). Integra Wound Matrix (Thin) has received 510(k) clearance from the United States Food and Drug Administration (FDA) and expects to begin a full market release in the United States in April 2014. Integra's newest skin product will be featured at the American Burn Association Annual Meeting, March 25 - 28, 2014, in Boston, Massachusetts.
Use Options For A Chance To Buy IART At A 28% Discount
at The Street - Fri Mar 21, 10:57AM CDT
Looking back to 135 days ago, Integra LifeSciences Holdings Corp priced a 3,500,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go...
First Laminoplasty Implant at Integra - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 5:00PM CDT
Integra LifeSciences announced the first human implantation of its Laminoplasty System in the U.S.
